PNPLA2 and Hyperglycemia: Similar to genetic loss of ATGL, Atglistatin attenuated hyperglycemia (Fig. 3a) and lipolysis (Fig. 3b–c, Supplementary Fig. S3a) and also improved insulin sensitivity (Fig. 3d–f) after HS.